首页> 外文期刊>Open Journal of Medicinal Chemistry >Design, Synthesis and Cancer Cell Line Activities of Pyrazolo[3,4-b]pyridine Derivatives
【24h】

Design, Synthesis and Cancer Cell Line Activities of Pyrazolo[3,4-b]pyridine Derivatives

机译:吡唑并[3,4-b]吡啶衍生物的设计,合成及癌细胞系活性

获取原文
       

摘要

Starting from 4,6-dimethyl-2-oxo-(1H)-3-pyridinecarbonitrile 1 and 3-aminopyrazolopyridine 4, a series of cyanopyri- dine derivatives 3a-i, Schiff bases 5a-f, urea and thiourea derivatives 6a-b, amide derivatives 7a-h, pyridopyra- zolopy-rimidine 8a-b and pyridopyrazolotriazine 10a-b were synthesized. Activities of eleven representative compounds were evaluated against A-549 (lung), HEPG2 (liver) and HCT-116 (colon) cancer cell lines. The findings revealed that some of the synthesized compounds showed remarkable anticancer activities, especially 8b which displayed the highest activity among the tested compounds with IC50 equal to 2.9, 2.6 and 2.3 μmol. In addition to synthesis and biological activities, we present discussion about the rationale of the design and activity of the potent compound 8b using struc- ture-based modeling tools.
机译:从4,6-二甲基-2-氧代(1H)-3-吡啶腈1和3-氨基吡唑并吡啶4开始,一系列氰基吡啶衍生物3a-i,席夫碱5a-f,脲和硫脲衍生物6a-b合成了酰胺衍生物7a-h,吡啶并吡唑并-嘧啶8a-b和吡啶并吡唑并三嗪10a-b。评估了11种代表性化合物对A-549(肺),HEPG2(肝)和HCT-116(结肠)癌细胞系的活性。结果表明,一些合成的化合物显示出显着的抗癌活性,尤其是8b,在被测化合物中具有最高的活性,IC50分别为2.9、2.6和2.3μmol。除合成和生物活性外,我们还将讨论基于结构的建模工具对强效化合物8b的设计和活性的基本原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号